Liver diseases unique to pregnancy: A 2010 update

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 3, 2011, Pages 182-193

  Bacq, Yannick ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; FATTY LIVER; FEMALE; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ACUTE DISEASE; CHOLESTASIS, INTRAHEPATIC; FATTY LIVER; FEMALE; HUMANS; LIVER DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

MLCS; MLOWN;

EID: 80052313763     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2010.11.011     Document Type: Short Survey

References (149)

1. Chazouilleres, O., Bacq, Y., Foie et grossesse. Gastroenterol Clin Biol 28 (2004), 84–91.
2. Hay, J.E., Liver disease in pregnancy. Hepatology 47 (2008), 1067–1076.
3. Joshi, D., James, A., Quaglia, A., Westbrook, R.H., Heneghan, M.A., Liver disease in pregnancy. Lancet 375 (2010), 594–605.
4. Chin, P.S., Wee, H.Y., Chern, B.S., Laparoscopic management of primary hepatic pregnancy. Aust N Z J Obstet Gynaecol 50 (2010), 95–98.
5. Paulino-Netto, A., Roselli, A., Hepatic ectopic pregnancy: successful surgical treatment of a patient with hepatic pregnancy and acute hemorrhage. Mt Sinai J Med 53 (1986), 514–517.
6. Shukla, V.K., Pandey, S., Pandey, L.K., Roy, S.K., Vaidya, M.P., Primary hepatic pregnancy. Postgrad Med J 61 (1985), 831–832.
7. Harris, G.J., Al-Jurf, A.S., Yuh, W.T., Abu-Yousef, M.M., Intrahepatic pregnancy. A unique opportunity for evaluation with sonography, computed tomography, and magnetic resonance imaging. JAMA 261 (1989), 902–904.
8. Delabrousse, E., Site, O., Le Mouel, A., Riethmuller, D., Kastler, B., Intrahepatic pregnancy: sonography and CT findings. AJR Am J Roentgenol 173 (1999), 1377–1378.
9. Shippey, S.H., Bhoola, S.M., Royek, A.B., Long, M.E., Diagnosis and management of hepatic ectopic pregnancy. Obstet Gynecol 109 (2007), 544–546.
10. Goodwin, T.M., Hyperemesis gravidarum. Clin Obstet Gynecol 41 (1998), 597–605.
11. Tsang, I.S., Katz, V.L., Wells, S.D., Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet 55 (1996), 231–235.
12. Bottomley, C., Bourne, T., Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol 23 (2009), 549–564.
13. Morali, G.A., Braverman, D.Z., Abnormal liver enzymes and ketonuria in hyperemesis gravidarum. A retrospective review of 80 patients. J Clin Gastroenterol 12 (1990), 303–305.
14. Hallak, M., Tsalamandris, K., Dombrowski, M.P., Isada, N.B., Pryde, P.G., Evans, M.I., Hyperemesis gravidarum. Effects on fetal outcome. J Reprod Med 41 (1996), 871–874.
15. Verberg, M.F., Gillott, D.J., Al-Fardan, N., Grudzinskas, J.G., Hyperemesis gravidarum, a literature review. Hum Reprod Update 11 (2005), 527–539.
16. Trogstad, L.I., Stoltenberg, C., Magnus, P., Skjaerven, R., Irgens, L.M., Recurrence risk in hyperemesis gravidarum. BJOG 112 (2005), 1641–1645.
17. Bacq, Y., Intrahepatic cholestasis of pregnancy. Clin Liver Dis 3 (1999), 1–13.
18. Geenes, V., Williamson, C., Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15 (2009), 2049–2066.
19. Reyes, H., Gonzalez, M.C., Ribalta, J., Aburto, H., Matus, C., Schramm, G., et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 88 (1978), 487–493.
20. Ribalta, J., Reyes, H., Gonzalez, M.C., Iglesias, J., Arrese, M., Poniachik, J., et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 13 (1991), 1084–1089.
21. Rioseco, A.J., Ivankovic, M.B., Manzur, A., Hamed, F., Kato, S.R., Parer, J.T., et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170 (1994), 890–895.
22. Laifer, S.A., Stiller, R.J., Siddiqui, D.S., Dunston-Boone, G., Whetham, J.C., Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 10 (2001), 131–135.
23. Lee, R.H., Goodwin, T.M., Greenspoon, J., Incerpi, M., The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26 (2006), 527–532.
24. Gonzalez, M.C., Reyes, H., Arrese, M., Figueroa, D., Lorca, B., Andresen, M., et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol 9 (1989), 84–90.
25. Glantz, A., Marschall, H.U., Mattsson, L.A., Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40 (2004), 467–474.
26. Reyes, H., The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 21 (1992), 905–921.
27. Bacq, Y., Sapey, T., Brechot, M.C., Pierre, F., Fignon, A., Dubois, F., Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 26 (1997), 358–364.
28. Favre, N., Abergel, A., Blanc, P., Sapin, V., Roszyk, L., Gallot, D., Unusual presentation of severe intrahepatic cholestasis of pregnancy leading to fetal death. Obstet Gynecol 114 (2009), 491–493.
29. Laatikainen, T., Tulenheimo, A., Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22 (1984), 91–94.
30. Egerman, R.S., Riely, C.A., Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient?. Hepatology 40 (2004), 287–288.
31. Dann, A.T., Kenyon, A.P., Seed, P.T., Poston, L., Shennan, A.H., Tribe, R.M., et al. S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 40 (2004), 1406–1414.
32. Goulis, D.G., Walker, I.A., de Swiet, M., Redman, C.W., Williamson, C., Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy 23 (2004), 19–27.
33. Atabey, S., Duvan, C.I., Eren, U., Turhan, N.O., Intrahepatic cholestasis and eclampsia: a case report. Hypertens Pregnancy 26 (2007), 363–369.
34. Vanjak, D., Moreau, R., Roche-Sicot, J., Soulier, A., Sicot, C., Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy. An unusual but favorable association?. Gastroenterology 100 (1991), 1123–1125.
35. Rolfes, D.B., Ishak, K.G., Liver disease in pregnancy. Histopathology 10 (1986), 555–570.
36. Ropponen, A., Sund, R., Riikonen, S., Ylikorkala, O., Aittomaki, K., Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43 (2006), 723–728.
37. Locatelli, A., Roncaglia, N., Arreghini, A., Bellini, P., Vergani, P., Ghidini, A., et al. C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 106 (1999), 498–500.
38. Paternoster, D.M., Fabris, F., Palu, G., Santarossa, C., Bracciante, R., Snijders, D., et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 81 (2002), 99–103.
39. Reyes, H., Simon, F.R., Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 13 (1993), 289–301.
40. Bacq, Y., Sapey, T., Cholestase intrahépatique gravidique. Gastroenterol Clin Biol 22 (1998), 705–713.
41. Diaferia, A., Nicastri, P.L., Tartagni, M., Loizzi, P., Iacovizzi, C., Di Leo, A., Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 52 (1996), 133–140.
42. Floreani, A., Paternoster, D., Melis, A., Grella, P.V., S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 67 (1996), 109–113.
43. Palma, J., Reyes, H., Ribalta, J., Hernandez, I., Sandoval, L., Almuna, R., et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 27 (1997), 1022–1028.
44. Nicastri, P.L., Diaferia, A., Tartagni, M., Loizzi, P., Fanelli, M., A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 105 (1998), 1205–1207.
45. Roncaglia, N., Locatelli, A., Arreghini, A., Assi, F., Cameroni, I., Pezzullo, J.C., et al. A randomised-controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG 111 (2004), 17–21.
46. Glantz, A., Marschall, H.U., Lammert, F., Mattsson, L.A., Intrahepatic cholestasis of pregnancy: a randomized-controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 42 (2005), 1399–1405.
47. Kondrackiene, J., Beuers, U., Kupcinskas, L., Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 129 (2005), 894–901.
48. Binder, T., Salaj, P., Zima, T., Vitek, L., Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 34 (2006), 383–391.
49. Liu, Y., Qiao, F., Liu, H., Liu, D., Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. J Huazhong Univ Sci Technolog Med Sci 26 (2006), 350–352.
50. Zapata, R., Sandoval, L., Palma, J., Hernandez, I., Ribalta, J., Reyes, H., et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 25 (2005), 548–554.
51. Sentilhes, L., Bacq, Y., La cholestase intrahépatique gravidique. J Gynecol Obstet Biol Reprod (Paris) 37 (2008), 118–126.
52. Frezza, M., Pozzato, G., Chiesa, L., Stramentinoli, G., Di Padova, C., Reserval of intrahepatic cholestasis of pregnancy in women after high dose S-Adenosyl-L-Methionine administration. Hepatology 4 (1984), 274–278.
53. Roncaglia, N., Arreghini, A., Locatelli, A., Bellini, P., Andreotti, C., Ghidini, A., Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 100 (2002), 167–170.
54. Saleh, M.M., Abdo, K.R., Consensus on the management of obstetric cholestasis: national UK survey. BJOG 114 (2007), 99–103.
55. Turunen, K., Sumanen, M., Haukilahti, R.L., Kirkinen, P., Mattila, K., Good pregnancy outcome despite intrahepatic cholestasis. Scand J Prim Health Care 28 (2010), 102–107.
56. Kenyon, A.P., Piercy, C.N., Girling, J., Williamson, C., Tribe, R.M., Shennan, A.H., Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 109 (2002), 282–288.
57. Mays, J.K., The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 22 (2010), 100–103.
58. Mozurkewich, E., Chilimigras, J., Koepke, E., Keeton, K., King, V.J., Indications for induction of labour: a best-evidence review. BJOG 116 (2009), 626–636.
59. Royal college of Obstetricians Gynaecologists, Obstetric cholestasis. RCOG Guidel 43 (2006), 1–10.
60. Menezes, E.V., Yakoob, M.Y., Soomro, T., Haws, R.A., Darmstadt, G.L., Bhutta, Z.A., Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy Childbirth, 9(Suppl. 1), 2009, S4.
61. Arrese, M., Macias, R.I., Briz, O., Perez, M.J., Marin, J.J., Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med, 10, 2008, e9.
62. Oude Elferink, R.P., Paulusma, C.C., Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 453 (2007), 601–610.
63. Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O., Hadchouel, M., Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 353 (1999), 210–211.
64. Dixon, P.H., Weerasekera, N., Linton, K.J., Donaldson, O., Chambers, J., Egginton, E., et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9 (2000), 1209–1217.
65. Mullenbach, R., Linton, K.J., Wiltshire, S., Weerasekera, N., Chambers, J., Elias, E., et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet, 40, 2003, e70.
66. Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C., et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 14 (2004), 91–102.
67. Floreani, A., Carderi, I., Paternoster, D., Soardo, G., Azzaroli, F., Esposito, W., et al. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 40 (2008), 366–370.
68. Gendrot, C., Bacq, Y., Brechot, M.C., Lansac, J., Andres, C., A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet, 40, 2003, e32.
69. Bacq, Y., Gendrot, C., Perrotin, F., Lefrou, L., Chretien, S., Vie-Buret, V., et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet 46 (2009), 711–715.
70. Rosmorduc, O., Hermelin, B., Poupon, R., MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 120 (2001), 1459–1467.
71. Rosmorduc, O., Hermelin, B., Boelle, P.Y., Parc, R., Taboury, J., Poupon, R., ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 125 (2003), 452–459.
72. Dixon, P.H., van Mil, S.W., Chambers, J., Strautnieks, S., Thompson, R.J., Lammert, F., et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58 (2009), 537–544.
73. Mullenbach, R., Bennett, A., Tetlow, N., Patel, N., Hamilton, G., Cheng, F., et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 54 (2005), 829–834.
74. Castano, G., Burgueno, A., Fernandez Gianotti, T., Pirola, C.J., Sookoian, S., The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Aliment Pharmacol Ther 31 (2010), 583–592.
75. Van Mil, S.W., Milona, A., Dixon, P.H., Mullenbach, R., Geenes, V.L., Chambers, J., et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133 (2007), 507–516.
76. Day, C., Hewins, P., Sheikh, L., Kilby, M., McPake, D., Lipkin, G., Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int 19 (2006), 1026–1029.
77. Meng, L.J., Reyes, H., Axelson, M., Palma, J., Hernandez, I., Ribalta, J., et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 26 (1997), 1573–1579.
78. Reyes, H., Sjovall, J., Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 32 (2000), 94–106.
79. Benifla, J.L., Dumont, M., Levardon, M., Foucher, E., Cadiot, G., Crenn-Hebert, C., et al. Effets de la progestérone naturelle micronisée sur le foie au cours du troisième trimestre de la grossesse. Contracept Fertil Sex 25 (1997), 165–169.
80. Wanggren, K., Sparre, L.S., Wramsby, H., Severe jaundice in early IVF pregnancy. Eur J Obstet Gynecol Reprod Biol 112 (2004), 228–229.
81. Reyes, H., Baez, M.E., Gonzales, M.C., Hernandez, I., Palma, J., Ribalta, J., et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 32 (2000), 542–549.
82. Sibai, B., Dekker, G., Kupferminc, M., Pre-eclampsia. Lancet 365 (2005), 785–799.
83. Barton, J.R., Sibai, B.M., Gastrointestinal complications of pre-eclampsia. Semin Perinatol 33 (2009), 179–188.
84. Weinstein, L., Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142 (1982), 159–167.
85. Sibai, B.M., Ramadan, M.K., Usta, I., Salama, M., Mercer, B.M., Friedman, S.A., Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 (1993), 1000–1006.
86. Miles, J.F. Jr., Martin, J.N. Jr., Blake, P.G., Perry, K.G. Jr., Martin, R.W., Meeks, G.R., Postpartum eclampsia: a recurring perinatal dilemma. Obstet Gynecol 76 (1990), 328–331.
87. Martin, J.N. Jr., Perry, K.G. Jr., Miles, J.F. Jr., Blake, P.G., Magann, E.F., Roberts, W.E., et al. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 100 (1993), 1095–1100.
88. Barton, J.R., Riely, C.A., Adamec, T.A., Shanklin, D.R., Khoury, A.D., Sibai, B.M., Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 167 (1992), 1538–1543.
89. Barton, J.R., Sibai, B.M., Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 174 (1996), 1820–1825 [discussion 5–7].
90. Zarrinpar, A., Farmer, D.G., Ghobrial, R.M., Lipshutz, G.S., Gu, Y., Hiatt, J.R., et al. Liver transplantation for HELLP syndrome. Am Surg 73 (2007), 1013–1016.
91. Zupan-Simunek, V., Prognosis in newborns after mother's preeclampsia. Ann Fr Anesth Reanim 29 (2010), e135–e139.
92. Miguelote, R.F., Costa, V., Vivas, J., Gonzaga, L., Menezes, C.A., Postpartum spontaneous rupture of a liver hematoma associated with preeclampsia and HELLP syndrome. Arch Gynecol Obstet 279 (2009), 923–926.
93. Ducarme, G., Bernuau, J., Luton, D., Liver and preeclampsia. Ann Fr Anesth Reanim 29 (2010), e97–e103.
94. Terasaki, K.K., Quinn, M.F., Lundell, C.J., Finck, E.J., Pentecost, M.J., Spontaneous hepatic hemorrhage in preeclampsia: treatment with hepatic arterial embolization. Radiology 174 (1990), 1039–1041.
95. Stain, S.C., Woodburn, D.A., Stephens, A.L., Katz, M., Wagner, W.H., Donovan, A.J., Spontaneous hepatic hemorrhage associated with pregnancy. Treatment by hepatic arterial interruption. Ann Surg 224 (1996), 72–78.
96. Rinehart, B.K., Terrone, D.A., Magann, E.F., Martin, R.W., May, W.L., Martin, J.N. Jr., Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome. Obstet Gynecol Surv 54 (1999), 196–202.
97. Pavlis, T., Aloizos, S., Aravosita, P., Mystakelli, C., Petrochilou, D., Dimopoulos, N., et al. Diagnosis and surgical management of spontaneous hepatic rupture associated with HELLP syndrome. J Surg Educ 66 (2009), 163–167.
98. Wicke, C., Pereira, P.L., Neeser, E., Flesch, I., Rodegerdts, E.A., Becker, H.D., Subcapsular liver hematoma in HELLP syndrome: evaluation of diagnostic and therapeutic options – a unicenter study. Am J Obstet Gynecol 190 (2004), 106–112.
99. Seren, G., Morel, J., Jospe, R., Mahul, P., Dumont, A., Cuileron, M., et al. HELLP syndrome and ruptured subcapsular hepatic haematoma. Case report and therapeutic options. Ann Fr Anesth Reanim 25 (2006), 1067–1069.
100. Descheemaeker, P.N., Compagnon, P., Lavoue, V., Seguin, P., Lechaux, D., Renaud-Giono, A., et al. Liver transplantation for subcapsular haematoma during HELLP Syndrome. Ann Fr Anesth Reanim 28 (2009), 1020–1022.
101. Reck, T., Bussenius-Kammerer, M., Ott, R., Muller, V., Beinder, E., Hohenberger, W., Surgical treatment of HELLP syndrome-associated liver rupture – an update. Eur J Obstet Gynecol Reprod Biol 99 (2001), 57–65.
102. Westbrook, R.H., Yeoman, A.D., Joshi, D., Heaton, N.D., Quaglia, A., O'Grady, J.G., et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 10 (2010), 2520–2526.
103. Sibai, B.M., Ramadan, M.K., Chari, R.S., Friedman, S.A., Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 172 (1995), 125–129.
104. Roberts, J.M., Cooper, D.W., Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001), 53–56.
105. Serrano, N.C., Immunology and genetic of preeclampsia. Clin Dev Immunol 13 (2006), 197–201.
106. Duckitt, K., Harrington, D., Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ, 330, 2005, 565.
107. Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006), 992–1005.
108. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004), 672–683.
109. Steinberg, G., Khankin, E.V., Karumanchi, S.A., Angiogenic factors and preeclampsia. Thromb Res 123:Suppl. 2 (2009), S93–S99.
110. Young, B., Levine, R.J., Salahuddin, S., Qian, C., Lim, K.H., Karumanchi, S.A., et al. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med 23 (2010), 366–370.
111. Strand, S., Strand, D., Seufert, R., Mann, A., Lotz, J., Blessing, M., et al. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology 126 (2004), 849–858.
112. Sheehan, H.L., The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Gynaecol 47 (1940), 49–62.
113. Pockros, P.J., Peters, R.L., Reynolds, T.B., Idiopathic fatty liver of pregnancy: findings in ten cases. Medicine (Baltimore) 63 (1984), 1–11.
114. Castro, M.A., Fassett, M.J., Reynolds, T.B., Shaw, K.J., Goodwin, T.M., Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 181 (1999), 389–395.
115. Reyes, H., Sandoval, L., Wainstein, A., Ribalta, J., Donoso, S., Smok, G., et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 35 (1994), 101–106.
116. Knight, M., Nelson-Piercy, C., Kurinczuk, J.J., Spark, P., Brocklehurst, P., A prospective national study of acute fatty liver of pregnancy in the UK. Gut 57 (2008), 951–956.
117. Monga, M., Katz, A.R., Acute fatty liver in the second trimester. Obstet Gynecol 93 (1999), 811–813.
118. Buytaert, I.M., Elewaut, G.P., Van Kets, H.E., Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol 91 (1996), 603–604.
119. Malone, F.D., Kaufman, G.E., Chelmow, D., Athanassiou, A., Nores, J.A., D'Alton, M.E., Maternal morbidity associated with triplet pregnancy. Am J Perinatol 15 (1998), 73–77.
120. Bacq, Y., La stéatose hépatique aiguë gravidique. Gastroenterol Clin Biol 21 (1997), 109–115.
121. Bacq, Y., Constans, T., Body, G., Choutet, P., Lamisse, F., La stéatose hépatique aiguë gravidique. J Gynecol Obstet Biol Reprod (Paris) 15 (1986), 851–861.
122. Riely, C.A., Acute fatty liver of pregnancy. Semin Liver Dis 7 (1987), 47–54.
123. Moldenhauer, J.S., O'Brien, J.M., Barton, J.R., Sibai, B., Acute fatty liver of pregnancy associated with pancreatitis: a life-threatening complication. Am J Obstet Gynecol 190 (2004), 502–505.
124. Castro, M.A., Ouzounian, J.G., Colletti, P.M., Shaw, K.J., Stein, S.M., Goodwin, T.M., Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med 41 (1996), 839–843.
125. Rolfes, D.B., Ishak, K.G., Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 5 (1985), 1149–1158.
126. Fesenmeier, M.F., Coppage, K.H., Lambers, D.S., Barton, J.R., Sibai, B.M., Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 192 (2005), 1416–1419.
127. Mjahed, K., Charra, B., Hamoudi, D., Noun, M., Barrou, L., Acute fatty liver of pregnancy. Arch Gynecol Obstet 274 (2006), 349–353.
128. Treem, W.R., Rinaldo, P., Hale, D.E., Stanley, C.A., Millington, D.S., Hyams, J.S., et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 19 (1994), 339–345.
129. Piech, J.J., Thieblot, P., Haberer, J.P., Delatour, M., Moinade, S., Gaillard, G., Grossesse gémellaire avec stéatose hépatique aiguë, puis insuffisance antéhypophysaire et diabète insipide. Presse Med 14 (1985), 1421–1423.
130. Bacq, Y., Assor, P., Gendrot, C., Perrotin, F., Scotto, B., Andres, C., Stéatose hépatique aiguë gravidique récidivante. Gastroenterol Clin Biol 31 (2007), 1135–1138.
131. Mabie, W.C., Acute fatty liver of pregnancy. Gastroenterol Clin North Am 21 (1992), 951–960.
132. Ockner, S.A., Brunt, E.M., Cohn, S.M., Krul, E.S., Hanto, D.W., Peters, M.G., Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 11 (1990), 59–64.
133. Remiszewski, P., Pawlak, J., Skwarek, A., Grzelak, I., Patkowski, W., Grodzicki, M., et al. Orthotopic liver transplantation for acute liver failure resulting from “acute fatty liver of pregnancy”. Ann Transplant 8 (2003), 8–11.
134. Amon, E., Allen, S.R., Petrie, R.H., Belew, J.E., Acute fatty liver of pregnancy associated with preeclampsia: management of hepatic failure with postpartum liver transplantation. Am J Perinatol 8 (1991), 278–279.
135. Gill, E.J., Contos, M.J., Peng, T.C., Acute fatty liver of pregnancy and acetaminophen toxicity leading to liver failure and postpartum liver transplantation. A case report. J Reprod Med 47 (2002), 584–586.
136. Schoeman, M.N., Batey, R.G., Wilcken, B., Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 100 (1991), 544–548.
137. Wilcken, B., Leung, K.C., Hammond, J., Kamath, R., Leonard, J.V., Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 341 (1993), 407–408.
138. Treem, W.R., Mitochondrial fatty acid oxidation and acute fatty liver of pregnancy. Semin Gastrointest Dis 13 (2002), 55–66.
139. Treem, W.R., Shoup, M.E., Hale, D.E., Bennett, M.J., Rinaldo, P., Millington, D.S., et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Gastroenterol 91 (1996), 2293–2300.
140. Sims, H.F., Brackett, J.C., Powell, C.K., Treem, W.R., Hale, D.E., Bennett, M.J., et al. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci U S A 92 (1995), 841–845.
141. Ibdah, J.A., Bennett, M.J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H.F., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340 (1999), 1723–1731.
142. Ibdah, J.A., Role of genetic screening in identifying susceptibility to acute fatty liver of pregnancy. Nat Clin Pract Gastroenterol Hepatol 2 (2005), 494–495.
143. Rector, R.S., Ibdah, J.A., Fatty acid oxidation disorders: maternal health and neonatal outcomes. Semin Fetal Neonatal Med 15 (2010), 122–128.
144. Innes, A.M., Seargeant, L.E., Balachandra, K., Roe, C.R., Wanders, R.J., Ruiter, J.P., et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 47 (2000), 43–45.
145. Matern, D., Hart, P., Murtha, A.P., Vockley, J., Gregersen, N., Millington, D.S., et al. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 138 (2001), 585–588.
146. Browning, M.F., Levy, H.L., Wilkins-Haug, L.E., Larson, C., Shih, V.E., Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 107 (2006), 115–120.
147. Mansouri, A., Fromenty, B., Durand, F., Degott, C., Bernuau, J., Pessayre, D., Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy. J Hepatol, 25, 1996, 781.
148. Rector, R.S., Payne, R.M., Ibdah, J.A., Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches. Adv Drug Deliv Rev 60 (2008), 1488–1496.
149. Natarajan, S.K., Thangaraj, K.R., Eapen, C.E., Ramachandran, A., Mukhopadhya, A., Mathai, M., et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology 51 (2010), 191–200.